Updates are available Correction dated 2019-08-09
Click to view Correction: https://doi.org/10.1038/s41575-019-0199-6
-
Authors
Sanders, Mary Ellen
Merenstein, Daniel J.
Reid, Gregor http://orcid.org/0000-0001-9658-5696
Gibson, Glenn R. http://orcid.org/0000-0002-0566-0476
Rastall, Robert A.
- License Information
-
More Information
Article History
Accepted: 14 June 2019
First Online: 11 July 2019
Change Date: 9 August 2019
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: M.E.S. declares personal fees related to probiotics from the following entities: California Dairy Research Foundation, Clorox, Danone, Danone USA, Dutch Mill, General Mills, JHeimbach, Kelley Drye & Warren, Kellogg, Kerry, Medscape, Nestle, New Chapter, Pepsico, Pfizer, Pharmavite, Probi, Procter & Gamble, Trouw Nutrition, Visalia Dairy Company, Williams Mullen, Winclove Probiotics and Yakult. D.J.M. declares personal fees for consulting for Bayer and Pharmavite. G.R. declares that he helped develop and commercialize probiotic strains GR-1 and RC-14, but has had no financial interest in them for over 10 years. He is Chief Scientific Officer for Seed, a company producing probiotic products. Over the past 3 years, he has consulted on probiotics with Acerus Pharmaceuticals, Altmann, Chr. Hansen, Danone, KGK Science, Kimberly-Clark, Metagenics and Seed. G.R.G. and R.A.R. declare no competing interests.
